Two Sigma Securities, LLC Ionis Pharmaceuticals Inc Put Options Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Put Options

13 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$40.06 - $51.86 $20,030 - $25,930
500 Added 10.64%
5,200 $208,000
Q2 2024

Aug 14, 2024
SELL
$36.45 - $47.7 $40,095 - $52,470
-1,100 Reduced 18.97%
4,700 $224,000
Q1 2024

May 15, 2024
BUY
$42.03 - $53.55 $46,233 - $58,905
1,100 Added 23.4%
5,800 $251,000
Q4 2023

Feb 14, 2024
SELL
$43.39 - $51.63 $104,136 - $123,912
-2,400 Reduced 33.8%
4,700 $237,000
Q3 2023

Nov 14, 2023
SELL
$38.5 - $47.13 $11,550 - $14,139
-300 Reduced 4.05%
7,100 $322,000
Q2 2023

Aug 14, 2023
BUY
$34.73 - $43.33 $257,001 - $320,642
7,400 New
7,400 $303,000
Q3 2022

Nov 14, 2022
BUY
$36.54 - $48.66 $193,662 - $257,897
5,300 New
5,300 $234,000
Q1 2022

May 16, 2022
BUY
$29.88 - $37.04 $206,172 - $255,576
6,900 New
6,900 $256,000
Q1 2020

May 15, 2020
SELL
$41.6 - $63.4 $199,680 - $304,320
-4,800 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$53.85 - $65.27 $522,345 - $633,119
-9,700 Reduced 66.9%
4,800 $290,000
Q3 2018

Nov 14, 2018
BUY
$42.88 - $53.7 $244,416 - $306,090
5,700 Added 64.77%
14,500 $748,000
Q2 2018

Aug 14, 2018
SELL
$40.53 - $50.7 $12,159 - $15,210
-300 Reduced 3.3%
8,800 $367,000
Q1 2018

May 15, 2018
BUY
$44.08 - $55.05 $401,128 - $500,955
9,100 New
9,100 $401,000

Others Institutions Holding IONS

# of Institutions
402
Shares Held
136M
Call Options Held
862K
Put Options Held
582K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.12B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email